CEACAM8 and cancer: Activated mature neutrophils defined as CD11cbright CD62Ldim CD11bbright CD16bright cells in healthy volunteers challenged with LPS systemically (52) and CD66b+ CD11bbright CD16bright mature LDNs in cancer patients (49) were reported to suppress T-cell proliferation.